Group 1 - The core viewpoint of the news is that Kefu Medical has seen a stock price increase of 5.24%, reaching 58.49 CNY per share, with a trading volume of 2.12 billion CNY and a market capitalization of 12.218 billion CNY as of January 12 [1] - Kefu Medical, established on November 19, 2009, and listed on October 25, 2021, is primarily engaged in the research, production, sales, and service of home medical devices [1] - The revenue composition of Kefu Medical includes rehabilitation aids at 43.12%, medical care products at 32.45%, health monitoring products at 20.76%, and other supplementary products at 3.68% [1] Group 2 - From the perspective of fund holdings, Kefu Medical is a significant investment for the Xingyin Fund, with the Xingyin Smart Consumer Mixed A Fund (018990) holding 83,800 shares, accounting for 4.1% of the fund's net value, making it the fifth-largest holding [2] - The Xingyin Smart Consumer Mixed A Fund was established on November 2, 2023, with a latest scale of 19.7561 million CNY, and has achieved a year-to-date return of 3.07% [2] - The fund has a one-year return of 32.34%, ranking 3994 out of 8157 in its category, and a cumulative return since inception of 30.42% [2]
可孚医疗股价涨5.24%，兴银基金旗下1只基金重仓，持有8.38万股浮盈赚取24.39万元